JP4614457B2 - Topical skin disease - Google Patents

Topical skin disease Download PDF

Info

Publication number
JP4614457B2
JP4614457B2 JP2006326845A JP2006326845A JP4614457B2 JP 4614457 B2 JP4614457 B2 JP 4614457B2 JP 2006326845 A JP2006326845 A JP 2006326845A JP 2006326845 A JP2006326845 A JP 2006326845A JP 4614457 B2 JP4614457 B2 JP 4614457B2
Authority
JP
Japan
Prior art keywords
dried
stock solution
mixed
skin disease
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2006326845A
Other languages
Japanese (ja)
Other versions
JP2008137963A (en
Inventor
哲 村上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2006326845A priority Critical patent/JP4614457B2/en
Publication of JP2008137963A publication Critical patent/JP2008137963A/en
Application granted granted Critical
Publication of JP4614457B2 publication Critical patent/JP4614457B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Description

本発明は、犬猫等の小型動物や馬牛等の大型動物における皮膚病治療に使用する外用剤に係わり、外用剤は薬草類と果実の抽出液を主原料とした石鹸及びローション並びにクリームに関するものである。   TECHNICAL FIELD The present invention relates to an external preparation used for the treatment of skin diseases in small animals such as dogs and cats and large animals such as horse cattle, and the external preparation relates to soaps and lotions and creams mainly using herbal extracts and fruit extracts. Is.

動物皮膚病外用剤の先行技術には、特開平6-179625号(特許文献1)、特開平10-139677号(特許文献2)、特開2001-321016(特許文献3)、特開2002-154975号(特許文献4)、特開2002-363065号(特許文献5)等がみられる。
この特許文献のうち特許文献5は本件出願人にかかるものであるが、いずれの特許文献も主として薬草を主原料とする外用治療剤に係わり、その治療効果を挙げており薬草もまた多種類である。
しかし、安定した治療剤とするためには、主原料より抽出した成分の濃度や調剤技術等が必要とされるにかかわらず配慮されていないと認められる。
特開平6−179625号公報 特開平10−139677号公報 特開2001−321016公報 特開2002−154975号公報 特開2002−363065号公報
Prior arts for topical animal skin diseases include JP-A-6-179625 (Patent Document 1), JP-A-10-139677 (Patent Document 2), JP-A-2001-321016 (Patent Document 3), JP-A-2002- No. 154975 (Patent Document 4), Japanese Patent Application Laid-Open No. 2002-363065 (Patent Document 5) and the like can be seen.
Of these patent documents, Patent Document 5 is related to the applicant of the present application. However, each patent document mainly relates to a therapeutic agent for external use mainly made of medicinal herbs, and has shown its therapeutic effect. is there.
However, in order to obtain a stable therapeutic agent, it is recognized that no consideration has been given to the concentration of ingredients extracted from the main raw materials and the preparation technique.
JP-A-6-179625 Japanese Patent Laid-Open No. 10-139677 JP 2001-321016 A JP 2002-154975 A Japanese Patent Laid-Open No. 2002-363065

本発明が解決しようとする問題点は、先行文献に記載される主原料の薬草や果物と同一又は類似に属するものを治療用主原料に使用するに当り、薬草から主成分を抽出する条件を共通とし、有機溶剤とグリセリンとを加えて混和を図ることにより、治療効果の安定した外用剤としようとするものである。   The problem to be solved by the present invention is that the conditions for extracting the main component from the herb are used in the case of using the same or similar to the main ingredient medicinal herb or fruit described in the prior literature as the main ingredient for treatment. It is intended to be an external preparation with a stable therapeutic effect by adding an organic solvent and glycerin and mixing them.

本件出願人は前記課題を解決するため本件出願人に係わる前記特許文献5における主原料を精査し整理して所要原料にまとめたうえ、その原料の成分抽出条件を共通とし、各抽出液の混合に当って果実のアルコール浸出液とグリセリンと芳香性果実液を加えることによりその目的を達成しようとするものである。   In order to solve the above-mentioned problems, the applicant of the present application carefully examines and arranges the main raw materials in Patent Document 5 related to the applicant and summarizes them into the required raw materials. In this process, the alcoholic leachate of fruit, glycerin and aromatic fruit liquid are added to achieve the purpose.

上記目的達成手段を具体的に記すと、原料のうち薬草はヨモギ・スギナ・緑茶葉・ドクダミ、果実は野ぶどう、芳香性果実油分はオレンジ油・レモン油の2種類である。上記4種類の薬草の抽出液を水に懸濁させるために、野ぶどうのアルコール度35°前後の焼酎漬け液とグリセリンとを使用する。   Specifically, the above means for achieving the purpose are medicinal herbs of mugwort, horsetail, green tea leaves and dokudami, fruits are wild grapes, and aromatic fruit oils are orange oil and lemon oil. In order to suspend the extracts of the above four kinds of herbs in water, shochu pickled liquor and glycerin with an alcohol degree of around 35 ° in the field grapes are used.

これら薬草は乾燥した一定重量のものを一定容量の水で煮つめて特定容量の薬効成分抽出液として使用し、野ぶどうの焼酎漬け液も上記の特定容量のものを使用する
These medicinal herbs are boiled with a constant volume of water and used as a specific volume of medicinal component extract, and the soy pickles of field grapes also have the above specific volume .

上記薬草の抽出液とグリセリンと芳香性果実液とから成る本発明外用剤主成分の混合比は、容量比で薬草抽出液4種類とも各3、野ぶどう焼酎漬け液1、芳香性果実油分のオレンジ油3・レモン油0.3、グリセリン5である。
上記中でスギナと茶葉とドクダミの抽出液は2までに減量させることが患者患部の症状によりできる。
The mixing ratio of the above-mentioned external preparations of the present invention consisting of the herbal extract, glycerin and aromatic fruit liquid is 3 for each of the 4 types of herbal extracts, 1 in the field grape shochu pickled liquid, and the aromatic fruit oil content. Orange oil 3, lemon oil 0.3 and glycerin 5.
Among the above, the extract of cedar, tea leaves and dokudami can be reduced to 2 depending on the symptoms of the affected area of the patient.

上記主成分を混合した主原液を、ローションすなわち患部洗浄水や化粧水とする場合には水に容量比で30%の割合で混合し、クリームローションとする場合には主原液3、クリーム5、水2の割合で混和し、石鹸の場合には主成分原液3、石鹸材料4、水3の割合で混和する。
前記主原液はアルカリ性であるから使用する水は酸性でない自然水が使用される。また、ローション類や石鹸化への手段についてはその業界における一般技術で行ってよい。
When the main stock solution mixed with the above main components is used as a lotion, that is, affected area washing water or lotion, it is mixed with water at a ratio of 30% by volume, and when it is used as a cream lotion, the main stock solution 3, cream 5, Mix in the proportion of water 2 and in the case of soap, mix in the proportion of the main ingredient stock solution 3, soap material 4, and water 3.
Since the main stock solution is alkaline, natural water that is not acidic is used. In addition, lotions and soaping means may be performed by general techniques in the industry.

本件出願人の出願にかかわる前記特許文献5ではその発明の効果を(表1)に示している。すなわち、犬の治療効果は重傷3〜4ヵ月、中傷1〜1.5ヵ月、軽傷1ヵ月以内、最長日数4.5ヵ月、最短日数10日である。本件発明による治療では上記により少なくとも10%以上短縮した結果を得ている。   In Patent Document 5 relating to the applicant's application, the effects of the invention are shown in (Table 1). That is, the therapeutic effect of dogs is 3-4 months for serious injuries, 1-1.5 months for slander, 1 month for minor injuries, 4.5 months for the longest day, and 10 days for the shortest day. In the treatment according to the present invention, the above results have been shortened by at least 10%.

上記効果の実例を記すと、本件発明の外用剤使用前の犬(雄1才・体重7kg・雑種)の既往歴は、
平成15年7月4日、鼻鏡に赤い発疹様のものが出現。更に眼の周りがただれてきたので近医(A病院)を受診したが、蚊に刺されたとの判断で経過観察となる。四肢及び全身に掻痒性が出現し、25日、再び受診したところ、アレルギーとの判断で抗生物質を投与される。掻痒性は悪化し、掻破した部分(おもに四肢)が出血して腫脹し、脱毛が始まったのでB病院に代えた。そこで膿皮症と判断され、抗生物質、かゆみ止め、ステロイドを投与されるも症状は悪化し、8月の中旬までには全身の大部分の被毛が脱落した。かゆみのために食欲も減退し、栄養状態が極めて悪くなった。B病院の内服治療に効果を感じず、C病院に代え、毛包虫症と判断され抗生物質と殺ダニ剤、シャンプー剤の処方を受けるが、病変に著変は見られず、むしろ増悪傾向をしめし、夜中の遠吠え、脱走、異常行動が始まったため、平成15年12月5日当方へ来店した。
As an example of the above effect, the history of the dog (male 1 year old, weight 7 kg, hybrid) before using the external preparation of the present invention is as follows:
On July 4, 2003, a red rash-like thing appeared on the nasal mirror. In addition, since the area around the eyes was drowned, I visited a nearby doctor (Hospital A). Pruritus appears in the limbs and the whole body, and when she visited the clinic again on the 25th, antibiotics were administered based on the judgment of allergy. The pruritus worsened, and the scratched part (mainly the extremities) bleeds and swells, and hair loss begins. Therefore, pyoderma was judged, and antibiotics, itching and steroids were given, but the symptoms worsened, and most of the whole body had fallen by mid-August. The appetite declined because of itching, and the nutritional status became extremely poor. Feels ineffective for internal treatment at Hospital B, replaces Hospital C, and is prescribed as antibiotics, acaricides, and shampoos. I went to the store on December 5, 2003 because of howling, escape, and abnormal behavior began at night.

本件発明の外用剤使用による治療経過は平成15年12月5日から開始した。ローション・クリームローション・石鹸を使用した。
(現症)
全身的に広汎な脱毛、紅潮がみられ、丘疹、血性の痂皮、掻破による出血がある。とくに顕著なのは両側面、後駆、両大腿後縁・肛門周囲、尾、四肢であり、舐性が強い。両大腿後縁から関節に至るまで広域性の脱毛と斑状の色素沈着が見られる。鼻鏡から鼻梁にかけて丘疹と掻破によって糜爛が存在するような状態になり、炎症が強い。栄養状態が悪く、痩せていて落ち着かない。
(経過)
外用療法開始翌日から掻痒性軽減し、行動が落ち着いてくる。12月19日(治療開始2週間)、脱毛は治らないものの、炎症が治まってきた。治療開始1ヵ月頃から全身の被毛がほぼ回復。栄養状態も良好になり、鼻鏡に若干炎症が残るが、2月15日完全治癒とした。体重も17kgになっていた。
The course of treatment using the external preparation of the present invention started on December 5, 2003. Lotion, cream lotion and soap were used.
(Current disease)
Extensive systemic hair loss, flushing, papules, bloody crusts, bleeding from scratches. Particularly noticeable are the bilateral side, the rear drive, both thigh trailing edges / anus, tail, and extremities, and has strong licking. Extensive hair loss and patchy pigmentation are seen from the thigh trailing edge to the joint. From the nasal mirror to the nasal bridge, the papules and scratches result in the presence of wrinkles and strong inflammation. Nutritional condition is poor, thin and restless.
(Progress)
From the day after the start of external therapy, the pruritus is reduced and the behavior becomes calm. On December 19th (2 weeks after the start of treatment), hair loss did not heal, but inflammation had subsided. Most of the whole body's hair recovered from the first month of treatment. The nutritional status improved, and the nasal mirror remained slightly inflamed, but it was completely cured on February 15. My weight was 17kg.

上記本件発明外用剤使用による治療経過を写真で示すと、図1、図2は平成15年12月8日の犬の症状を示し、図3、図4は平成16年1月16日の、図5、図6は平成16年2月15日の症状を示す。   When the treatment course by the use of the above external preparation of the present invention is shown in photographs, FIGS. 1 and 2 show the symptoms of the dog on December 8, 2003, and FIGS. 3 and 4 show the results on January 16, 2004. 5 and 6 show the symptoms on February 15, 2004.

本発明外用剤の調合の実施例を詳記すると、日陰で乾燥したヨモギ、スギナ、緑茶葉、ドクダミそれぞれ500gを水6リットルとともに400ccになるまで煮つめ個々の抽出液とする。生のドクダミを用いる場合は1.5kgとする。野ぶどうは500gをアルコール度35°の焼酎に漬け保存(好ましくは3ヵ年)した液を用いる。オレンジ油・レモン油はそれぞれの皮を乾燥させた後に粉砕し容器に入れ蒸気で蒸して湿潤させ、これを脱水機にかけて絞りとったエキスである。   The preparation examples of the preparation for external use of the present invention will be described in detail. 500 g each of mugwort, horsetail, green tea leaves and dokudami dried in the shade are boiled together with 6 liters of water to 400 cc to obtain individual extracts. When using raw dokudami, weigh 1.5kg. For the field grapes, use a solution of 500g in a shochu with an alcohol content of 35 ° (preferably 3 years). Orange oil and lemon oil are extracts obtained by drying each skin, crushing it, placing it in a container, steaming it with steam and moistening it, and then squeezing it through a dehydrator.

上記によるものの調合は、ヨモギ抽出液30ccとスギナ・緑茶葉・ドクダミ各抽出液各20ccとを水650ccに混和し、グリセリン50ccと野ぶどうの焼酎液10ccとを加えて充分に混合し、オレンジ油30ccとレモン油2ccとを添加して主原材料とする。これをローションやクリームローションや石鹸の主材料とするものである。   For the preparation of the above, 30cc mugwort extract and 20cc each extract of sugina, green tea leaves, and dokudami are mixed in 650cc water, add 50cc glycerin and 10cc wild grape shochu liquor, and mix well. Add 30cc and 2cc of lemon oil to make main ingredients. This is the main ingredient of lotion, cream lotion and soap.

平成15年12月8日の犬の症状を示した写真。A photograph showing the symptoms of the dog on December 8, 2003. 図1の他側面の症状を示した写真。The photograph which showed the symptom of the other side of FIG. 平成16年1月16日の犬の症状を示した写真。A photograph showing the symptoms of the January 16, 2004 dog. 図3の拡大写真。The enlarged photograph of FIG. 平成16年2月15日の犬の治癒状態を示した写真。A photograph showing the dog's healing status on February 15, 2004. 図5の拡大写真。The enlarged photograph of FIG.

Claims (3)

乾燥ヨモギと乾燥スギナと乾燥緑茶葉と乾燥ドクダミの各500gを水6リットルで煮つめて各400ccとして個々の成分抽出液とし、各成分抽出液を3単位容量、野ぶどうの焼酎漬け液1単位容量、グリセリン5単位容量、芳香性果実油成分のオレンジ油3単位容量・レモン油0.3単位容量を混合して主原液としこれを水に懸濁して使用する皮膚疾患外用剤。   500g each of dried mugwort, dried horsetail, dried green tea leaves and dried dokudami is boiled in 6 liters of water to make each component extract as 400cc, each component extract is 3 unit capacity, 1 unit volume of field grape shochu pickled solution A skin disease preparation for external use in which 5 unit volumes of glycerin, 3 units volume of orange oil of aromatic fruit oil components and 0.3 unit volume of lemon oil are mixed and used as a main stock solution. 請求項1における該主原液を水に30%混合してローションとした皮膚疾患外用剤。   The external preparation for skin diseases in which the main stock solution according to claim 1 is mixed with 30% of water to make a lotion. 請求項1における該主原液をクリームローション或いは石鹸の材料に30%混合した皮膚疾患外用剤。   A skin disease external preparation comprising 30% of the main stock solution according to claim 1 mixed with a cream lotion or soap material.
JP2006326845A 2006-12-04 2006-12-04 Topical skin disease Active JP4614457B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006326845A JP4614457B2 (en) 2006-12-04 2006-12-04 Topical skin disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006326845A JP4614457B2 (en) 2006-12-04 2006-12-04 Topical skin disease

Publications (2)

Publication Number Publication Date
JP2008137963A JP2008137963A (en) 2008-06-19
JP4614457B2 true JP4614457B2 (en) 2011-01-19

Family

ID=39599813

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006326845A Active JP4614457B2 (en) 2006-12-04 2006-12-04 Topical skin disease

Country Status (1)

Country Link
JP (1) JP4614457B2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1087504A (en) * 1996-09-06 1998-04-07 Fumio Iizuka Production of dermatophytosis therapeutic agent
JP2005015364A (en) * 2003-06-25 2005-01-20 Maruzen Pharmaceut Co Ltd Anti-oxidizing composition, skin ageing-preventing composition, anti-inflammatory composition and lipid metabolism-improving composition
JP2006045181A (en) * 2003-11-18 2006-02-16 Sekisui Chem Co Ltd External composition for skin
JP2006193495A (en) * 2005-01-17 2006-07-27 Kao Corp Cosmetic

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1087504A (en) * 1996-09-06 1998-04-07 Fumio Iizuka Production of dermatophytosis therapeutic agent
JP2005015364A (en) * 2003-06-25 2005-01-20 Maruzen Pharmaceut Co Ltd Anti-oxidizing composition, skin ageing-preventing composition, anti-inflammatory composition and lipid metabolism-improving composition
JP2006045181A (en) * 2003-11-18 2006-02-16 Sekisui Chem Co Ltd External composition for skin
JP2006193495A (en) * 2005-01-17 2006-07-27 Kao Corp Cosmetic

Also Published As

Publication number Publication date
JP2008137963A (en) 2008-06-19

Similar Documents

Publication Publication Date Title
TWI221768B (en) Pharmaceutical composition comprising histamine H1 receptor antagonist and histamine H3 receptor antagonist providing nasal decongestant effect
CN105079214A (en) Emulsion containing traditional Chinese medicine extracting solution and used for treating eczema and preparation method thereof
JP5908402B2 (en) Method for preventing renal disease and treating symptoms thereof
JP4614457B2 (en) Topical skin disease
Conrick Neem: the ultimate herb
JPH01199916A (en) Drug for external use
JP6240626B2 (en) Anti-atopic dermatitis composition
CN103271832A (en) Synephrine loaded multiple emulsion and preparation method thereof
JP4312992B2 (en) Antiallergic agent
DE602004007164T2 (en) TRANSPORT AND ABSORPTION AGENTS AND THE METHOD OF ITS MANUFACTURE FROM HEMS
JP2022153490A (en) Colloidal silver combined with plant extracts for use in treating wounds and other skin conditions
CN103157071B (en) Chinese herbal compound film for treating dermatomycosis and preparation method thereof
WO2009115216A1 (en) Use of a component or extract from the baobab plant for skin diseases
CN104189681A (en) Compounded Chinese and western medicine gel for treating bromhidrosis and preparation method of compounded Chinese and western medicine gel
JP2006298944A (en) Insulin-like growth factor-1 secretagogue
CN1813987A (en) Immunoreaction regulator of eliminating skin and mucous membrane irritability
JPH027568B2 (en)
JPH11322627A (en) Antiallergic external composition for skin
JPH1160465A (en) Cosmetic containing liquid of pyroligneous acid and liquid of pyroligneous acid of bamboo
JP4124318B2 (en) Antioxidants and external preparations for skin
CN105943587A (en) External use type adnate elder herb ointment for treating impact injuries and sprains and preparing method thereof
JP2008120776A (en) External preparation for skin
JPS59155306A (en) Hair-growing promoter
JP2002173434A (en) Antiallergic composition
KR20030021991A (en) Acne Remedies

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100817

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100825

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100914

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100917

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20101013

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20101018

R150 Certificate of patent or registration of utility model

Ref document number: 4614457

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131029

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250